Accessibility Menu
Idorsia logo

Idorsia

(OTC) IDRSF

Current Price$7.50
Market Cap$1.91B
Since IPO (2017)-58%
5 Year-75%
1 Year+233%
1 Month+30%

Idorsia Financials at a Glance

Market Cap

$1.91B

Revenue (TTM)

CHF 219.10M

Net Income (TTM)

-CHF 221.11M

EPS (TTM)

-$1.19

P/E Ratio

-6.31

Dividend

$0.00

Beta (Volatility)

-0.04 (Low)

Price

$7.50

Volume

41,726

Open

$6.00

Previous Close

$7.50

Daily Range

$6.00 - $7.70

52-Week Range

$2.25 - $7.70

Estimated Earnings Date

Jul 30, 2026

IDRSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Idorsia

Industry

Biotechnology

Employees

487

CEO

Jean-Paul Clozel, MD

Headquarters

Allschwil, 4123, CH

IDRSF Financials

Key Financial Metrics (TTM)

Gross Margin

88%

Operating Margin

-96%

Net Income Margin

-1%

Return on Equity

0%

Return on Capital

-63%

Return on Assets

-46%

Earnings Yield

-15.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.91B

Shares Outstanding

255.04M

Volume

41.73K

Avg. Volume

1.27K

Financials (TTM)

Gross Profit

CHF 182.31M

Operating Income

-CHF 116.38M

EBITDA

-CHF 45.49M

Operating Cash Flow

-CHF 153.23M

Capital Expenditure

-CHF 13.82M

Free Cash Flow

-CHF 167.05M

Cash & ST Invst.

CHF 87.24M

Total Debt

CHF 1.27B

Idorsia Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CHF 57.39M

-2.5%

Gross Profit

CHF 49.33M

-12.6%

Gross Margin

85.95%

N/A

Market Cap

$1.91B

N/A

Market Cap/Employee

$1.74M

N/A

Employees

1,100

N/A

Net Income

-CHF 45.70M

-172.4%

EBITDA

-CHF 22.77M

-130.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CHF 94.70M

+46.0%

Total Debt

CHF 1.32B

+5.3%

Accounts Receivable

CHF 55.26M

+62.9%

Inventory

CHF 78.30M

+25.3%

Long Term Debt

CHF 1.31B

+25.6%

Short Term Debt

CHF 22.69M

-89.1%

Return on Assets

-45.95%

N/A

Return on Invested Capital

-63.36%

N/A

Free Cash Flow

-CHF 28.25M

+53.6%

Operating Cash Flow

-CHF 26.63M

+56.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WHTCFWELL Health Technologies Corp.
$3.09-0.10%
BPMUFBasilea Pharmaceutica AG
$60.28+0.00%
NNCSFNanosonics Limited
$2.36+0.00%
INRLFValneva SE
$2.58+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$185.00-0.04%
NOKNokia
$13.49-0.02%
AALAmerican Airlines Group
$15.99+0.04%
TAT&T
$22.01-0.02%

Questions About IDRSF

What is the current price of Idorsia?

Idorsia is trading at $7.50 per share.

What is the 52-week range for Idorsia?

Over the past 52 weeks, Idorsia has traded between $2.25 and $7.70.

How much debt does Idorsia have?

As of the most recent reporting period, Idorsia reported total debt of CHF 1.67B.

How much cash does Idorsia have on hand?

Idorsia reported CHF 117.85M in cash and cash equivalents in its most recent financial results.

What is Idorsia’s dividend yield?

Idorsia does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.